Connect with us

Hi, what are you looking for?

News

Slowing Enterprise Buying Environment Should Weigh On Docebo In 2023 (NASDAQ:DCBO)

A Quick Take On Docebo

Docebo Inc. (NASDAQ:DCBO) provides a suite of online learning capabilities with AI-enhanced functions to improve learning results for organizations of all sizes.

I previously wrote about Docebo with a Buy outlook.

Measure [TTM]

Amount

Enterprise Value / Sales

7.0

Enterprise Value / EBITDA

NM

Price / Sales

8.4

Revenue Growth Rate

33.0%

Net Income Margin

10.0%

EBITDA %

-1.7%

Net Debt To Annual EBITDA

83.0

Market Capitalization

$1,280,000,000

Enterprise Value

$1,060,000,000

Operating Cash Flow

$2,080,000

Earnings Per Share (Fully Diluted)

$0.44

Metric [TTM]

Instructure

Docebo

Variance

Enterprise Value / Sales

8.5

7.0

-18.3%

Enterprise Value / EBITDA

29.7

NM

–%

Revenue Growth Rate

15.5%

33.0%

113.1%

Net Income Margin

-8.3%

10.0%

–%

Operating Cash Flow

$125,300,000

$2,080,000

-98.3%

Rule of 40 Performance

Q3 2022

Q1 2023

Revenue Growth %

43.5%

33.0%

EBITDA %

-7.3%

-1.7%

Total

36.2%

31.3%

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

Follow Play Earnings CallPlay Earnings Call Disc Medicine, Inc. (IRON) Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs...

Videos

Watch full video on YouTube